Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine vs remifentanil for postoperative analgesia after pulmonary surgery
ChiCTR2400093594Phase 4Not yet recruiting
- Sponsor
- Shanghai Fourth People's Hospital
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nalbuphine in postoperative pain (2 arms), sponsored by Shanghai Fourth People's Hospital. Primary endpoint: Percentage of time on qualified analgesia in 1h after surgery. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
nalbuphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400093594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093594.